-
1
-
-
0033524378
-
Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte
-
DOI 10.1002/(SICI)1097-0215(19990105)80:1<92::AID
-
Nukaya I, Yasumoto M, Iwasaki T, et al: Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte. Int J Cancer 80: 92-97, 1999. (Pubitemid 28559783)
-
(1999)
International Journal of Cancer
, vol.80
, Issue.1
, pp. 92-97
-
-
Nukaya, I.1
Yasumoto, M.2
Iwasaki, T.3
Ideno, M.4
Sette, A.5
Celis, E.6
Takesako, K.7
Kato, I.8
-
2
-
-
0033882792
-
+ cytotoxic T lymphocytes
-
DOI 10.1002/1097-0215(20000815)87:4<553::AID
-
Ikuta Y, Okugawa T, Furugen R, et al: A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes. Int J Cancer 87: 553-558, 2000. (Pubitemid 30639816)
-
(2000)
International Journal of Cancer
, vol.87
, Issue.4
, pp. 553-558
-
-
Ikuta, Y.1
Okugawa, T.2
Furugen, R.3
Nagata, Y.4
Takahashi, Y.5
Wang, L.6
Ikeda, H.7
Watanabe, M.8
Imai, S.9
Shiku, H.10
-
3
-
-
0026645959
-
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E
-
Traversari C, van der Bruggen P, Luescher IF, et al: A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176: 1453-1457, 1992.
-
(1992)
J Exp Med
, vol.176
, pp. 1453-1457
-
-
Traversari, C.1
Van Der Bruggen, P.2
Luescher, I.F.3
-
4
-
-
0027980103
-
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
-
Gaugler B, van den Eynde B, van der Bruggen P, et al: Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179: 921-930, 1994. (Pubitemid 24065650)
-
(1994)
Journal of Experimental Medicine
, vol.179
, Issue.3
, pp. 921-930
-
-
Gaugler, B.1
Van Den, E.B.2
Van Der, B.P.3
Romero, P.4
Gaforio, J.J.5
De Plaen, E.6
Lethe, B.7
Brasseur, F.8
Boon, T.9
-
5
-
-
0029028642
-
Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line
-
Bakker AB, Schreurs MW, Tafazzul G, et al: Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line. Int J Cancer 62: 97-102, 1995.
-
(1995)
Int J Cancer
, vol.62
, pp. 97-102
-
-
Bakker, A.B.1
Schreurs, M.W.2
Tafazzul, G.3
-
6
-
-
0029997742
-
Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens
-
DOI 10.1002/(SICI)1097-0215(19960410)66:2<162::AID
-
Jaeger E, Bernhard H, Romero P, et al: Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer 66: 162-169, 1996. (Pubitemid 26248194)
-
(1996)
International Journal of Cancer
, vol.66
, Issue.2
, pp. 162-169
-
-
Jaeger, E.1
Bernhard, H.2
Romero, P.3
Ringhoffer, M.4
Arand, M.5
Karbach, J.6
Ilsemann, C.7
Hagedorn, M.8
Knuth, A.9
-
7
-
-
0031890206
-
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
-
DOI 10.1038/nm0398-321
-
Rosenberg SA, Yang JC, Schwartzentruber DJ, et al: Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 4: 321-327, 1998. (Pubitemid 28144091)
-
(1998)
Nature Medicine
, vol.4
, Issue.3
, pp. 321-327
-
-
Rosenberg, S.A.1
Yang, J.C.2
Schwartzentruber, D.J.3
Hwu, P.4
Marincola, F.M.5
Topalian, S.L.6
Restifo, N.P.7
Dudley, M.E.8
Schwarz, S.L.9
Spiess, P.J.10
Wunderlich, J.R.11
Parkhurst, M.R.12
Kawakami, Y.13
Seipp, C.A.14
Einhorn, J.H.15
White, D.E.16
-
8
-
-
0026561063
-
A novel quasi-viral agent, MaTu, is a two-component system
-
Pastorekova S, Zavadova Z, Kostal M, et al: A novel quasi-viral agent, MaTu, is a two-component system. Virology 187: 620-626, 1992.
-
(1992)
Virology
, vol.187
, pp. 620-626
-
-
Pastorekova, S.1
Zavadova, Z.2
Kostal, M.3
-
9
-
-
0030835515
-
Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney
-
Liao SY, Aurelio ON, Jan K, et al: Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 57: 2827-2831, 1997. (Pubitemid 27315020)
-
(1997)
Cancer Research
, vol.57
, Issue.14
, pp. 2827-2831
-
-
Liao, S.-Y.1
Aurelio, O.N.2
Jan, K.3
Zavada, J.4
Stanbridge, E.J.5
-
10
-
-
0030972193
-
MN antigen expression in normal, preneoplastic, and neoplastic esophagus: A clinicopathological study of a new cancer-associated biomarker
-
DOI 10.1016/S0046-8177(97)90185-4
-
Turner JR, Odze RD, Crum CP, et al: MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker. Hum Pathol 28: 740-744, 1997. (Pubitemid 27258429)
-
(1997)
Human Pathology
, vol.28
, Issue.6
, pp. 740-744
-
-
Turner, J.R.1
Odze, R.D.2
Crum, C.P.3
Resnick, M.B.4
-
11
-
-
0031819881
-
Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation
-
Saarnio J, Parkkila S, Parkkila AK, et al: Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 153: 279-285, 1998. (Pubitemid 28317531)
-
(1998)
American Journal of Pathology
, vol.153
, Issue.1
, pp. 279-285
-
-
Saarnio, J.1
Parkkila, S.2
Parkkila, A.-K.3
Haukipuro, K.4
Pastorekova, S.5
Pastorek, J.6
Kairaluoma, M.I.7
Karttunen, T.J.8
-
12
-
-
0032755017
-
Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma
-
DOI 10.1034/j.1399-3003.1999.14d14.x
-
Vermylen P, Roufosse C, Burny A, et al: Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. Eur Respir J 14: 806-811,1999. (Pubitemid 29519341)
-
(1999)
European Respiratory Journal
, vol.14
, Issue.4
, pp. 806-811
-
-
Vermylen, P.1
Roufosse, C.2
Burny, A.3
Verhest, A.4
Bosschaerts, T.5
Pastorekova, S.6
Ninane, V.7
Sculier, J.-P.8
-
13
-
-
0027981949
-
Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas
-
Liao SY, Brewer C, Zavada J, et al: Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 145: 598-609, 1994. (Pubitemid 24285967)
-
(1994)
American Journal of Pathology
, vol.145
, Issue.3
, pp. 598-609
-
-
Liao, S.Y.1
Brewer, C.2
Zavada, J.3
Pastorek, J.4
Pastorekova, S.5
Manetta, A.6
Berman, M.L.7
DiSaia, P.J.8
Stanbridge, E.J.9
-
14
-
-
15644384121
-
Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity
-
Saarnio J, Parkkila S, Parkkila AK, et al: Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity. J Histochem Cytochem 46: 497-504, 1998. (Pubitemid 28158469)
-
(1998)
Journal of Histochemistry and Cytochemistry
, vol.46
, Issue.4
, pp. 497-504
-
-
Saarnio, J.1
Parkkila, S.2
Parkkila, A.-K.3
Waheed, A.4
Casey, M.C.5
Zhou, X.Y.6
Pastorekova, S.7
Pastorek, J.8
Karttunen, T.9
Haukipuro, K.10
Kairaluoma, M.I.11
Sly, W.S.12
-
15
-
-
0032886302
-
MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas
-
DOI 10.1038/sj.bjc.6690757
-
Uemura H, Nakagawa Y, Yoshida K, et al: MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br J Cancer 81: 741-746, 1999. (Pubitemid 29458875)
-
(1999)
British Journal of Cancer
, vol.81
, Issue.4
, pp. 741-746
-
-
Uemura, H.1
Nakagawa, Y.2
Yoshida, K.3
Saga, S.4
Yoshikawa, K.5
Hirao, Y.6
Oosterwijk, E.7
-
16
-
-
0021052516
-
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human LEU-3/T4 molecule
-
Dialynas DP, Quan ZS, Wall KA, et al: Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 131: 2445-2451, 1983. (Pubitemid 14230079)
-
(1983)
Journal of Immunology
, vol.131
, Issue.5
, pp. 2445-2451
-
-
Dialynas, D.P.1
Quan, Z.S.2
Wall, K.A.3
-
17
-
-
0031204947
-
Peptides Derived from a Wild-Type Murine Proto-Oncogene c-erbB-2/HER2/neu Can Induce CTL and Tumor Suppression in Syngeneic Hosts
-
Nagata Y, Furugen R, Hiasa A, et al: Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. J Immunol 159: 1336-1343, 1997. (Pubitemid 127484112)
-
(1997)
Journal of Immunology
, vol.159
, Issue.3
, pp. 1336-1343
-
-
Nagata, Y.1
Furugen, R.2
Hiasa, A.3
Ikeda, H.4
Ohta, N.5
Furukawa, K.6
Nakamura, H.7
Furukawa, K.8
Kanematsu, T.9
Shiku, H.10
-
18
-
-
0028922319
-
Chemistry of peptides associated with MHC class I and class II molecules
-
Rammensee HG: Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol 7: 85-96, 1995.
-
(1995)
Curr Opin Immunol
, vol.7
, pp. 85-96
-
-
Rammensee, H.G.1
-
19
-
-
0025952222
-
T-cell immunotherapy of cancer
-
Melief CJ and Kast WM: T-cell immunotherapy of cancer. Res Immunol 142: 425-429, 1991.
-
(1991)
Res Immunol
, vol.142
, pp. 425-429
-
-
Melief, C.J.1
Kast, W.M.2
-
20
-
-
0027370248
-
Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene
-
DOI 10.1006/cimm.1993.1233
-
Ioannides CG, Fisk B, Fan D, et al: Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene. Cell Immunol 151: 225-234, 1993. (Pubitemid 23308446)
-
(1993)
Cellular Immunology
, vol.151
, Issue.1
, pp. 225-234
-
-
Ioannides, C.G.1
Fisk, B.2
Fan, D.3
Biddison, W.E.4
Wharton, J.T.5
O'Brian, C.A.6
-
21
-
-
0030996710
-
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A
-
Cormier JN, Salgaller ML, Prevette T, et al: Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A. Cancer J Sei Am 3: 37-44, 1997.
-
(1997)
Cancer J Sei Am
, vol.3
, pp. 37-44
-
-
Cormier, J.N.1
Salgaller, M.L.2
Prevette, T.3
-
22
-
-
0034880680
-
Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas
-
Sadanaga N, Nagashima H, Mashino K, et al: Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. Clin Cancer Res 7: 2277-2284, 2001. (Pubitemid 32751625)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.8
, pp. 2277-2284
-
-
Sadanaga, N.1
Nagashima, H.2
Mashino, K.3
Tahara, K.4
Yamaguchi, H.5
Ohta, M.6
Fujie, T.7
Tanaka, F.8
Inoue, H.9
Takesako, K.10
Akiyoshi, T.11
Mori, M.12
-
23
-
-
0030057504
-
DNA typing of the HLA-A gene: Population study and identification of four new alleles in Japanese
-
Date Y, Kimura A, Kato H, et al: DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens 47: 93-101, 1996. (Pubitemid 26067938)
-
(1996)
Tissue Antigens
, vol.47
, Issue.2
, pp. 93-101
-
-
Date, Y.1
Kimura, A.2
Kato, H.3
Sasazuki, T.4
|